{
"info": {
"nct_id": "NCT04054531",
"official_title": "An Open-label, Phase II Study of KN046 Evaluating the Efficacy and Safety of KN046 Plus Platinum-based Doublet Chemotherapy as First Line Therapy in Advanced Non-small Cell Lung Cancer Subjects.",
"inclusion_criteria": "* Has a histologically or cytologically confirmed diagnosis of stage IV NSCLC;\n* Has not received prior systemic treatment for metastatic NSCLC;\n* Has measurable disease based on RECIST 1.1.\n* Has a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) Performance Status.\n* Has adequate organ function.\n* Has provided tumor tissue from locations not radiated prior to biopsy.\n\nKey\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 75 Years",
"exclusion_criteria": "* Previous immunotherapy (e.g. anti-PD-1, anti-PD-L1, anti-PD-L2, anti-CTLA-4 antibody, or any other antibody or drug specifically targeting T-cell co-stimulation or immune checkpoint pathways)\n* Previously untreated or symptomatic central nervous system (CNS) metastases\n* Has received a live-virus vaccination within 28 days of planned treatment start.\n* Previously had a severe hypersensitivity reaction to treatment with another monoclonal antibody and chemotherapy.\n* Has or had active autoimmune disease.",
"miscellaneous_criteria": "Key"
},
"inclusion_lines": [
{
"line": "* Has a histologically or cytologically confirmed diagnosis of stage IV NSCLC;",
"criterions": [
{
"exact_snippets": "histologically or cytologically confirmed diagnosis of stage IV NSCLC",
"criterion": "NSCLC diagnosis",
"requirements": [
{
"requirement_type": "confirmation method",
"expected_value": [
"histologically",
"cytologically"
]
},
{
"requirement_type": "stage",
"expected_value": "IV"
}
]
}
]
},
{
"line": "* Has not received prior systemic treatment for metastatic NSCLC;",
"criterions": [
{
"exact_snippets": "Has not received prior systemic treatment",
"criterion": "prior systemic treatment for metastatic NSCLC",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Has measurable disease based on RECIST 1.1.",
"criterions": [
{
"exact_snippets": "Has measurable disease based on RECIST 1.1.",
"criterion": "measurable disease",
"requirements": [
{
"requirement_type": "measurement standard",
"expected_value": "RECIST 1.1"
}
]
}
]
},
{
"line": "* Has a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) Performance Status.",
"criterions": [
{
"exact_snippets": "performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) Performance Status",
"criterion": "ECOG Performance Status",
"requirements": [
{
"requirement_type": "value",
"expected_value": [
"0",
"1"
]
}
]
}
]
},
{
"line": "* Has adequate organ function.",
"criterions": [
{
"exact_snippets": "adequate organ function",
"criterion": "organ function",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": true
}
]
}
]
},
{
"line": "* Has provided tumor tissue from locations not radiated prior to biopsy.",
"criterions": [
{
"exact_snippets": "provided tumor tissue",
"criterion": "tumor tissue",
"requirements": [
{
"requirement_type": "provision",
"expected_value": true
}
]
},
{
"exact_snippets": "locations not radiated prior to biopsy",
"criterion": "tumor tissue location",
"requirements": [
{
"requirement_type": "radiation status",
"expected_value": "not radiated prior to biopsy"
}
]
}
]
},
{
"line": "Key",
"criterions": [
{
"exact_snippets": "Key",
"criterion": "key",
"requirements": [
{
"requirement_type": "N/A",
"expected_value": "N/A"
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
},
{
"line": "Must have maximum age of 75 Years",
"criterions": [
{
"exact_snippets": "maximum age of 75 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 75,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Previous immunotherapy (e.g. anti-PD-1, anti-PD-L1, anti-PD-L2, anti-CTLA-4 antibody, or any other antibody or drug specifically targeting T-cell co-stimulation or immune checkpoint pathways)",
"criterions": [
{
"exact_snippets": "Previous immunotherapy (e.g. anti-PD-1, anti-PD-L1, anti-PD-L2, anti-CTLA-4 antibody, or any other antibody or drug specifically targeting T-cell co-stimulation or immune checkpoint pathways)",
"criterion": "previous immunotherapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Previously untreated or symptomatic central nervous system (CNS) metastases",
"criterions": [
{
"exact_snippets": "Previously untreated ... central nervous system (CNS) metastases",
"criterion": "central nervous system (CNS) metastases",
"requirements": [
{
"requirement_type": "treatment status",
"expected_value": "untreated"
}
]
},
{
"exact_snippets": "symptomatic central nervous system (CNS) metastases",
"criterion": "central nervous system (CNS) metastases",
"requirements": [
{
"requirement_type": "symptom presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Has received a live-virus vaccination within 28 days of planned treatment start.",
"criterions": [
{
"exact_snippets": "Has received a live-virus vaccination within 28 days of planned treatment start.",
"criterion": "live-virus vaccination",
"requirements": [
{
"requirement_type": "time since vaccination",
"expected_value": {
"operator": "<=",
"value": 28,
"unit": "days"
}
}
]
}
]
},
{
"line": "* Previously had a severe hypersensitivity reaction to treatment with another monoclonal antibody and chemotherapy.",
"criterions": [
{
"exact_snippets": "Previously had a severe hypersensitivity reaction to treatment with another monoclonal antibody",
"criterion": "hypersensitivity reaction to monoclonal antibody",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "severe"
},
{
"requirement_type": "temporal",
"expected_value": "previously"
}
]
},
{
"exact_snippets": "Previously had a severe hypersensitivity reaction to treatment with ... chemotherapy",
"criterion": "hypersensitivity reaction to chemotherapy",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "severe"
},
{
"requirement_type": "temporal",
"expected_value": "previously"
}
]
}
]
},
{
"line": "* Has or had active autoimmune disease.",
"criterions": [
{
"exact_snippets": "Has or had active autoimmune disease",
"criterion": "autoimmune disease",
"requirements": [
{
"requirement_type": "activity",
"expected_value": true
}
]
}
]
}
],
"miscellaneous_lines": [
{
"line": "Key",
"criterions": [
{
"exact_snippets": "Key",
"criterion": "key",
"requirements": [
{
"requirement_type": "N/A",
"expected_value": "N/A"
}
]
}
]
}
],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}